Ezquer F - Search Results

1

Methadone directly impairs central nervous system cells in vitro.

De Gregorio C, Gallardo J, Berríos-Cárcamo P, Handy Á, Santapau D, González-Madrid A, Ezquer M, Morales P, Luarte A, Corvalán D, Wyneken Ú, Ezquer F. De Gregorio C, et al. Among authors: ezquer f. Sci Rep. 2024 Jul 23;14(1):16978. doi: 10.1038/s41598-024-67860-7. Sci Rep. 2024. PMID: 39043899 Free PMC article.

2

Differential distribution of low-density lipoprotein-receptor-related protein (LRP) and megalin in polarized epithelial cells is determined by their cytoplasmic domains.

Marzolo MP, Yuseff MI, Retamal C, Donoso M, Ezquer F, Farfán P, Li Y, Bu G. Marzolo MP, et al. Among authors: ezquer f. Traffic. 2003 Apr;4(4):273-88. doi: 10.1034/j.1600-0854.2003.00081.x. Traffic. 2003. PMID: 12694565 Free article.

3

Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Ezquer FE, et al. Biol Blood Marrow Transplant. 2008 Jun;14(6):631-40. doi: 10.1016/j.bbmt.2008.01.006. Epub 2008 Apr 14. Biol Blood Marrow Transplant. 2008. PMID: 18489988 Free article.

4

Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

Ezquer F, Ezquer M, Simon V, Pardo F, Yañez A, Carpio D, Conget P. Ezquer F, et al. Among authors: ezquer m. Biol Blood Marrow Transplant. 2009 Nov;15(11):1354-65. doi: 10.1016/j.bbmt.2009.07.022. Biol Blood Marrow Transplant. 2009. PMID: 19822294 Free article.

5

The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.

Ezquer F, Ezquer M, Simon V, Conget P. Ezquer F, et al. Among authors: ezquer m. PLoS One. 2011 Jan 27;6(1):e16566. doi: 10.1371/journal.pone.0016566. PLoS One. 2011. PMID: 21304603 Free PMC article.

6

Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.

Ezquer M, Ezquer F, Ricca M, Allers C, Conget P. Ezquer M, et al. Among authors: ezquer f. J Hepatol. 2011 Nov;55(5):1112-20. doi: 10.1016/j.jhep.2011.02.020. Epub 2011 Feb 26. J Hepatol. 2011. PMID: 21356258

7

The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.

Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P. Ezquer F, et al. Among authors: ezquer m. Stem Cells. 2012 Aug;30(8):1664-74. doi: 10.1002/stem.1132. Stem Cells. 2012. PMID: 22644660

8

MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.

Ezquer ME, Ezquer FE, Arango-Rodríguez ML, Conget PA. Ezquer ME, et al. Biol Res. 2012;45(3):289-96. doi: 10.4067/S0716-97602012000300010. Biol Res. 2012. PMID: 23283438 Free article. Review.

9

Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?

Ezquer F, Ezquer M, Arango-Rodriguez M, Conget P. Ezquer F, et al. Among authors: ezquer m. Acta Ophthalmol. 2014 Mar;92(2):e86-95. doi: 10.1111/aos.12113. Epub 2013 Jun 15. Acta Ophthalmol. 2014. PMID: 23773776 Free article. Review.

10

Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Arango-Rodriguez ML, Ezquer F, Ezquer M, Conget P. Arango-Rodriguez ML, et al. Among authors: ezquer m, ezquer f. World J Stem Cells. 2015 Mar 26;7(2):408-17. doi: 10.4252/wjsc.v7.i2.408. World J Stem Cells. 2015. PMID: 25815124 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters